The effectiveness of this shelf registration opens the door for immediate share sales by 3i, LP. With a $2M market cap and up to 3.95M shares potentially hitting the market, severe downward price pressure is likely. Traders should watch for a Form 424B5 or prospectus supplement announcing a takedown, which could trigger a sharp sell-off.
Price Chart
Executive Summary
Valion Bio's S-3 shelf registration (File No. 333-299355) became effective on October 20, 2026, enabling the resale of up to 3,954,381 shares of common stock by the selling stockholder 3i, LP. The shares are issuable upon conversion of Series B and Series C preferred stock and exercise of warrants, creating a large potential dilution overhang for a company with a $2M market cap.
Key Facts
- Shelf registration (S-3) became effective on October 20, 2026.
- Up to 3,954,381 shares of common stock may be resold by selling stockholder 3i, LP.
- Shares are issuable upon conversion of 1,850 shares of Series B Preferred (at $3.62) and 7,637 shares of Series C Preferred (at $3.62), plus exercise of warrants.
- Market cap is approximately $2M, making the potential dilution massive relative to current float.
- The S-3 was filed on October 16, 2026, and became effective in 4 days.
Financial Impact
Up to 3,954,381 shares of common stock could be sold into the market, representing a huge dilution relative to a $2M market cap. At current prices, the offering could be worth several times the company's entire market capitalization.
Risk Factors
- Massive dilution from conversion of preferred stock and exercise of warrants.
- Selling stockholder 3i, LP may begin selling immediately, flooding the market.
- Company has a very small market cap ($2M), making it highly sensitive to any share sales.
Market Snapshot
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (Primary) | 9999999995-26-003301 |
| Document: 9999999995-26-003301-index.html | 9999999995-26-003301 |
| Document: 9999999995-26-003301.txt | 9999999995-26-003301 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 27, 2026 today | 8-K | $0.8950 | awaiting T+20 | — | $0.8400 (+6.15%) |
Oct 26, 2026 1d ago | 8-K | $0.8400 | awaiting T+20 | — | $0.8400 (−0.00%) |
Oct 22, 2026 5d ago | 8-K | $0.9560 | awaiting T+20 | — | $0.8400 (−12.13%) |
Oct 21, 2026 6d ago | EFFECT | $1.12 | awaiting T+20 | — | $0.8400 (+25.00%) |
Oct 21, 2026 6d ago | EFFECT | $1.12 | awaiting T+20 | — | $0.8400 (+25.00%) |
Oct 16, 2026 11d ago | S-3 | $1.16 | awaiting T+20 | — | $0.8400 (+27.59%) |
Oct 16, 2026 11d ago | DEF 14A | $1.16 | awaiting T+20 | — | $0.8400 (+27.59%) |
Oct 15, 2026 12d ago | 8-K | $1.23 | awaiting T+20 | — | $0.8400 (−31.71%) |
Oct 14, 2026 13d ago | 8-K | $1.45 | awaiting T+20 | — | $0.8400 (−42.07%) |
Oct 8, 2026 19d ago | 8-K | $2.21 | awaiting T+20 | — | $0.8400 (+61.99%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers